To determine whether AKT E17K mutations occur in melanoma, we used a mass spectroscopy-based approach designed to detect single-nucleotide polymorphisms (SNPs) to determine the frequency of this activating mutation in AKT1, AKT2, and AKT3 isoforms in a large panel of human melanoma specimens and human cell lines. Here, AKT2 is linked to melanoma.